Lipocine (LPCN) Stock: Buy, Sell, or Hold?
LPCN - Lipocine Inc.
$2.27
0.02 (0.89%)
â˛
5d:
-6.2%
30d:
+10.19%
90d:
+3.18%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When LPCN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LPCN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LPCN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LPCN is currently trading at $2.27, which is considered slightly high relative to its 30-day fair value range of $2.06 to $2.30.
Technical Outlook: Technically, LPCN is in a downtrend. Immediate support is located at $2.13, while resistance sits at $2.50.
Market Sentiment: LPCN scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+164.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LPCN is in a downtrend. Immediate support is located at $2.13, while resistance sits at $2.50.
Market Sentiment: LPCN scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+164.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.06 -
$2.30
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 164.3% below Wall St target ($6.00)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.06 -
$2.30
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.13
Resistance Level
$2.50
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.38
Wall Street Target
$6.00
(+164.3%)
Revenue Growth (YoY)
-69.5%
Share & Embed Analysis
Last updated: September 13, 2026 10:06 AM ET
Data refreshes hourly during market hours. Next update: 11:06 AM
Data refreshes hourly during market hours. Next update: 11:06 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LPCN showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John W Higuchi
BUY
40000 shares
2026-04-07
John W Higuchi
BUY
123000 shares
2026-04-06
Mahesh V Patel
BUY
25000 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
